Mindy Manning Douglas, CRNA | |
303 Medical Center Dr, Batesville, MS 38606-8608 | |
(866) 362-6963 | |
(866) 362-4202 |
Full Name | Mindy Manning Douglas |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 11 Years |
Location | 303 Medical Center Dr, Batesville, Mississippi |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679913750 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | R876132 (Mississippi) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | 21221 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baptist Memorial Hospital North Ms | Oxford, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gastroenterology Center Of The Midsouth Pllc | 4880619824 | 138 |
Lifelinc Anesthesia Pllc | 0941347447 | 144 |
Willow Anesthesia Services, Llc | 9234279183 | 28 |
News Archive
Medical device company ICON Interventional Systems, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe) alloy.
Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
In related news, The New York Times reports that state and federal exchanges are using "happy talk" to market the new health coverage options available through the online insurance marketplaces, but they rarely mention the penalty. Other news outlets report on developments from Maryland, Oregon and Colorado.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
› Verified 2 days ago
Entity Name | Gastroenterology Center Of The Midsouth Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417932492 PECOS PAC ID: 4880619824 Enrollment ID: O20051010000483 |
News Archive
Medical device company ICON Interventional Systems, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe) alloy.
Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
In related news, The New York Times reports that state and federal exchanges are using "happy talk" to market the new health coverage options available through the online insurance marketplaces, but they rarely mention the penalty. Other news outlets report on developments from Maryland, Oregon and Colorado.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
› Verified 2 days ago
Entity Name | Willow Anesthesia Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205169521 PECOS PAC ID: 9234279183 Enrollment ID: O20091228000308 |
News Archive
Medical device company ICON Interventional Systems, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe) alloy.
Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
In related news, The New York Times reports that state and federal exchanges are using "happy talk" to market the new health coverage options available through the online insurance marketplaces, but they rarely mention the penalty. Other news outlets report on developments from Maryland, Oregon and Colorado.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
› Verified 2 days ago
Entity Name | Premier Anesthesia Of Mississippi Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033400197 PECOS PAC ID: 5597933036 Enrollment ID: O20110801000660 |
News Archive
Medical device company ICON Interventional Systems, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe) alloy.
Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
In related news, The New York Times reports that state and federal exchanges are using "happy talk" to market the new health coverage options available through the online insurance marketplaces, but they rarely mention the penalty. Other news outlets report on developments from Maryland, Oregon and Colorado.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
› Verified 2 days ago
Entity Name | Lifelinc Anesthesia Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801021464 PECOS PAC ID: 0941347447 Enrollment ID: O20130522000277 |
News Archive
Medical device company ICON Interventional Systems, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe) alloy.
Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
In related news, The New York Times reports that state and federal exchanges are using "happy talk" to market the new health coverage options available through the online insurance marketplaces, but they rarely mention the penalty. Other news outlets report on developments from Maryland, Oregon and Colorado.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mindy Manning Douglas, CRNA 716 W Brookhaven Cir, Memphis, TN 38117-4504 Ph: (901) 844-1590 | Mindy Manning Douglas, CRNA 303 Medical Center Dr, Batesville, MS 38606-8608 Ph: (866) 362-6963 |
News Archive
Medical device company ICON Interventional Systems, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe) alloy.
Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
In related news, The New York Times reports that state and federal exchanges are using "happy talk" to market the new health coverage options available through the online insurance marketplaces, but they rarely mention the penalty. Other news outlets report on developments from Maryland, Oregon and Colorado.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
› Verified 2 days ago
Kristina Lynn Hintzsche, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 303 Medical Center Dr, Batesville, MS 38606 Phone: 662-550-4299 Fax: 662-580-4324 | |
William Kline, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 303 Medical Center Dr, Batesville, MS 38606 Phone: 662-563-5611 | |
David Garret Mccullen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 303 Medical Center Dr, Batesville, MS 38606 Phone: 662-563-0155 |